Titre : Chenopodium ambrosioïdes

Chenopodium ambrosioïdes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Complement Activation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Chenopodium ambrosioïdes : Questions médicales les plus fréquentes", "headline": "Chenopodium ambrosioïdes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Chenopodium ambrosioïdes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-13", "dateModified": "2025-03-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Chenopodium ambrosioïdes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Chenopodium", "url": "https://questionsmedicales.fr/mesh/D027462", "about": { "@type": "MedicalCondition", "name": "Chenopodium", "code": { "@type": "MedicalCode", "code": "D027462", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.198.500.100.666" } } }, "about": { "@type": "MedicalCondition", "name": "Chenopodium ambrosioïdes", "alternateName": "Chenopodium ambrosioides", "code": { "@type": "MedicalCode", "code": "D027464", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "David E Jarvis", "url": "https://questionsmedicales.fr/author/David%20E%20Jarvis", "affiliation": { "@type": "Organization", "name": "Plant and Wildlife Sciences Department, Brigham Young University, Provo, Utah, USA." } }, { "@type": "Person", "name": "Hossein Ghanizadeh", "url": "https://questionsmedicales.fr/author/Hossein%20Ghanizadeh", "affiliation": { "@type": "Organization", "name": "School of Agriculture and Environment, Massey University, Palmerston North, New Zealand." } }, { "@type": "Person", "name": "Kerry C Harrington", "url": "https://questionsmedicales.fr/author/Kerry%20C%20Harrington", "affiliation": { "@type": "Organization", "name": "School of Agriculture and Environment, Massey University, Palmerston North, New Zealand." } }, { "@type": "Person", "name": "Eric N Jellen", "url": "https://questionsmedicales.fr/author/Eric%20N%20Jellen", "affiliation": { "@type": "Organization", "name": "Plant and Wildlife Sciences Department, Brigham Young University, Provo, Utah, USA." } }, { "@type": "Person", "name": "Shu-Han Yu", "url": "https://questionsmedicales.fr/author/Shu-Han%20Yu", "affiliation": { "@type": "Organization", "name": "Institute of Biotechnology, National Taiwan University, No. 1, Sec. 4, Roosevelt Rd, Taipei 10617, Taiwan, ROC." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Complement-Coagulation Cross-talk: Factor H-mediated regulation of the Complement Classical Pathway activation by fibrin clots.", "datePublished": "2024-06-12", "url": "https://questionsmedicales.fr/article/38933264", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2024.1368852" } }, { "@type": "ScholarlyArticle", "name": "Synthetic Oligodeoxynucleotide CpG Motifs Activate Human Complement through Their Backbone Structure and Induce Complement-Dependent Cytokine Release.", "datePublished": "2022-09-14", "url": "https://questionsmedicales.fr/article/36104112", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4049/jimmunol.2101191" } }, { "@type": "ScholarlyArticle", "name": "Inter-Individual Variations: A Challenge for the Standardisation of Complement Activation Assays.", "datePublished": "2023-02-11", "url": "https://questionsmedicales.fr/article/36816333", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/IJN.S384184" } }, { "@type": "ScholarlyArticle", "name": "Modeling complement activation on human glomerular microvascular endothelial cells.", "datePublished": "2023-10-25", "url": "https://questionsmedicales.fr/article/37954621", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2023.1206409" } }, { "@type": "ScholarlyArticle", "name": "Complement C3 activation in the ICU: Disease and therapy as Bonnie and Clyde.", "datePublished": "2022-07-16", "url": "https://questionsmedicales.fr/article/35853795", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.smim.2022.101640" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Eucaryotes", "item": "https://questionsmedicales.fr/mesh/D056890" }, { "@type": "ListItem", "position": 3, "name": "Viridiplantae", "item": "https://questionsmedicales.fr/mesh/D057948" }, { "@type": "ListItem", "position": 4, "name": "Streptophyta", "item": "https://questionsmedicales.fr/mesh/D057949" }, { "@type": "ListItem", "position": 5, "name": "Embryophyta", "item": "https://questionsmedicales.fr/mesh/D019669" }, { "@type": "ListItem", "position": 6, "name": "Tracheobionta", "item": "https://questionsmedicales.fr/mesh/D064028" }, { "@type": "ListItem", "position": 7, "name": "Magnoliopsida", "item": "https://questionsmedicales.fr/mesh/D019684" }, { "@type": "ListItem", "position": 8, "name": "Caryophyllanae", "item": "https://questionsmedicales.fr/mesh/D000074427" }, { "@type": "ListItem", "position": 9, "name": "Caryophyllales", "item": "https://questionsmedicales.fr/mesh/D000073559" }, { "@type": "ListItem", "position": 10, "name": "Amaranthaceae", "item": "https://questionsmedicales.fr/mesh/D027703" }, { "@type": "ListItem", "position": 11, "name": "Chenopodium", "item": "https://questionsmedicales.fr/mesh/D027462" }, { "@type": "ListItem", "position": 12, "name": "Chenopodium ambrosioïdes", "item": "https://questionsmedicales.fr/mesh/D027464" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Chenopodium ambrosioïdes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Chenopodium ambrosioïdes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Chenopodium ambrosioïdes", "description": "Comment diagnostiquer une intoxication par Chenopodium ambrosioïdes ?\nQuels tests sont utilisés pour confirmer une intoxication ?\nQuels signes cliniques indiquent une intoxication ?\nY a-t-il des examens d'imagerie nécessaires ?\nComment différencier une intoxication d'une allergie ?", "url": "https://questionsmedicales.fr/mesh/D027464?mesh_terms=Complement+Activation&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Chenopodium ambrosioïdes", "description": "Quels sont les symptômes courants d'une intoxication ?\nPeut-on avoir des réactions cutanées ?\nLes symptômes sont-ils immédiats ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon la dose ?", "url": "https://questionsmedicales.fr/mesh/D027464?mesh_terms=Complement+Activation&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Chenopodium ambrosioïdes", "description": "Comment prévenir l'intoxication par Chenopodium ambrosioïdes ?\nY a-t-il des groupes à risque ?\nComment identifier la plante dans la nature ?\nDes conseils pour la culture de la plante ?\nFaut-il des précautions lors de la manipulation ?", "url": "https://questionsmedicales.fr/mesh/D027464?mesh_terms=Complement+Activation&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Chenopodium ambrosioïdes", "description": "Quel est le traitement principal en cas d'intoxication ?\nDes antidotes spécifiques existent-ils ?\nQuand faut-il consulter un médecin ?\nLes traitements sont-ils différents pour les enfants ?\nPeut-on utiliser des remèdes naturels pour traiter l'intoxication ?", "url": "https://questionsmedicales.fr/mesh/D027464?mesh_terms=Complement+Activation&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Chenopodium ambrosioïdes", "description": "Quelles complications peuvent survenir après une intoxication ?\nL'intoxication peut-elle entraîner des problèmes neurologiques ?\nY a-t-il des risques à long terme ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D027464?mesh_terms=Complement+Activation&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Chenopodium ambrosioïdes", "description": "Quels sont les facteurs de risque d'intoxication ?\nLes personnes allergiques sont-elles plus à risque ?\nLes animaux domestiques sont-ils à risque ?\nLes personnes âgées sont-elles plus vulnérables ?\nL'usage récréatif augmente-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D027464?mesh_terms=Complement+Activation&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication par Chenopodium ambrosioïdes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et les symptômes cliniques observés." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer une intoxication ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et urinaires peuvent être effectués pour détecter des métabolites spécifiques." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une intoxication ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des nausées, vomissements, et des douleurs abdominales." } }, { "@type": "Question", "name": "Y a-t-il des examens d'imagerie nécessaires ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Généralement, les examens d'imagerie ne sont pas nécessaires pour l'intoxication." } }, { "@type": "Question", "name": "Comment différencier une intoxication d'une allergie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'intoxication présente des symptômes digestifs, tandis que l'allergie provoque des réactions cutanées." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une intoxication ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, vomissements, diarrhée et douleurs abdominales." } }, { "@type": "Question", "name": "Peut-on avoir des réactions cutanées ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des éruptions cutanées peuvent survenir en cas d'allergie ou d'irritation." } }, { "@type": "Question", "name": "Les symptômes sont-ils immédiats ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître rapidement, généralement dans les heures suivant l'ingestion." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes neurologiques comme des vertiges peuvent survenir dans les cas graves." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la dose ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité des symptômes dépend de la quantité ingérée de la plante." } }, { "@type": "Question", "name": "Comment prévenir l'intoxication par Chenopodium ambrosioïdes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez la consommation de la plante sans avis médical et informez-vous sur ses effets." } }, { "@type": "Question", "name": "Y a-t-il des groupes à risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants et les femmes enceintes sont plus vulnérables aux effets de la plante." } }, { "@type": "Question", "name": "Comment identifier la plante dans la nature ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Chenopodium ambrosioïdes a des feuilles dentelées et une odeur forte, souvent décrite comme médicinale." } }, { "@type": "Question", "name": "Des conseils pour la culture de la plante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Cultivez-la dans un endroit éloigné des enfants et des animaux pour éviter l'ingestion accidentelle." } }, { "@type": "Question", "name": "Faut-il des précautions lors de la manipulation ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, portez des gants lors de la manipulation pour éviter les irritations cutanées." } }, { "@type": "Question", "name": "Quel est le traitement principal en cas d'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste en des soins de soutien, comme l'hydratation et le contrôle des symptômes." } }, { "@type": "Question", "name": "Des antidotes spécifiques existent-ils ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique pour l'intoxication par Chenopodium ambrosioïdes." } }, { "@type": "Question", "name": "Quand faut-il consulter un médecin ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de consulter un médecin en cas de symptômes sévères ou persistants." } }, { "@type": "Question", "name": "Les traitements sont-ils différents pour les enfants ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent nécessiter des soins spécifiques en raison de leur sensibilité." } }, { "@type": "Question", "name": "Peut-on utiliser des remèdes naturels pour traiter l'intoxication ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Il est préférable d'éviter les remèdes naturels sans avis médical, car ils peuvent aggraver les symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une intoxication ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des troubles gastro-intestinaux prolongés et des déshydratations." } }, { "@type": "Question", "name": "L'intoxication peut-elle entraîner des problèmes neurologiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes neurologiques peuvent survenir dans les cas d'intoxication sévère." } }, { "@type": "Question", "name": "Y a-t-il des risques à long terme ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des effets à long terme sont possibles, notamment des troubles digestifs chroniques." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications graves sont rares mais peuvent survenir dans des cas d'ingestion massive." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications doivent être gérées par des soins médicaux appropriés et un suivi régulier." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'intoxication ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la consommation non contrôlée et l'absence de connaissances sur la plante." } }, { "@type": "Question", "name": "Les personnes allergiques sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant des antécédents d'allergies peuvent être plus sensibles aux effets." } }, { "@type": "Question", "name": "Les animaux domestiques sont-ils à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les animaux peuvent également être affectés par l'ingestion de la plante." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir une tolérance réduite et des complications plus graves." } }, { "@type": "Question", "name": "L'usage récréatif augmente-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'usage récréatif sans connaissance des effets peut augmenter le risque d'intoxication." } } ] } ] }

Sources (10000 au total)

Synthetic Oligodeoxynucleotide CpG Motifs Activate Human Complement through Their Backbone Structure and Induce Complement-Dependent Cytokine Release.

Bacterial and mitochondrial DNA, sharing an evolutionary origin, act as danger-associated molecular patterns in infectious and sterile inflammation. They both contain immunomodulatory CpG motifs. Inte...

Inter-Individual Variations: A Challenge for the Standardisation of Complement Activation Assays.

The role of the human immune system in pathologic responses to chemicals including nanomaterials was identified as a gap in current hazard assessments. However, the complexity of the human immune syst... We treated commercially available pooled sera (PS) from healthy males, individual sera from healthy donors and from patients suffering from cancer, immunodeficiency and allergies with small molecules ... The level of complement activation in PS differed significantly from responses of individual donors (p < 0.01). Only seven out of 32 investigated sera from healthy donors responded similarly to the po... Our studies demonstrate that the use of pooled serum can lead to an over- or under-estimation of immunological response in particular for individuals with pre-existing pathologies. This is of high rel...

Modeling complement activation on human glomerular microvascular endothelial cells.

Atypical hemolytic uremic syndrome (aHUS) is a rare kidney disease caused by dysregulation of the complement alternative pathway. The complement dysregulation specifically leads to damage to the glome... Endothelial cells were incubated with human test sera and stained with an anti-C5b-9 antibody to visualize and quantify complement depositions on the cells with immunofluorescence microscopy.... First, we showed that zymosan-activated sera resulted in increased endothelial C5b-9 depositions compared to normal human serum (NHS). The levels of C5b-9 depositions were similar between conditionall... In conclusion, we demonstrate a robust and reliable model to adequately measure C5b-9-based complement deposition on human control and patient ciGMVECs. This model can be used to study the pathophysio...

DAMPS and complement activation in platelet concentrates that induce adverse reactions in patients.

Patients with severe thrombocytopenia due to bone marrow failure and after chemotherapy are still treated with platelet transfusions. Platelet concentrates (PC) are associated with a high incidence of... Single donor apheresis platelet concentrates (SDA PCs) were produced in a regional setting of the French Blood Establishment. After transfusion samples were collected from PC and possible AR in patien... A total of 56 PC were included in the study. 30 PC induced no AR, and 26 induced AR (Febrile non-hemolytic transfusion reaction n = 16; Atypical Allergic Transfusion Reactions n = 11; hemodynamic inst... In this study, we observed an association between HMGB1 and CAP and the incidence of AR. Furthermore, we demonstrated that both HMGB1 and complement activation were correlated to platelet activation....

Minimal role for the alternative pathway in complement activation by HIT immune complexes.

Anti-platelet factor 4 (PF4)/heparin immune complexes that cause heparin-induced thrombocytopenia (HIT) activate complement via the classical pathway. Previous studies have shown that the alternative ... These studies sought to examine the contributions of the alternative pathway to complement activation by HIT antibodies.... Using IgG monoclonal (KKO) and/or patient-derived HIT antibodies, we compared the effects of classical pathway (BBK32 and C1-esterase inhibitor [C1-INH]), alternative pathway (anti-factor B [fB] or fa... Classical pathway inhibitors BBK32 and C1-INH and the combined classical/alternative pathway inhibitor sCR1 prevented KKO/HIT immune complex-induced complement activation, including release of C3 and ... Collectively, these findings suggest the alternative pathway contributes little in support of complement activation by HIT immune complexes. Additional in vitro and in vivo studies are required to exa...